On behalf of the Organising Committee, it is our great honour and privilege to invite you to attend the 32nd Scientific Meeting of the International Society of Hypertension (ISH 2027), held in conjunction with the Chinese Hypertension Meeting 2027 (CHM 2027) and the 29th International Symposium on Hypertension and Related Diseases. The congress will take place from 28–31 October 2027 in Shanghai, China.

This meeting marks a significant milestone as ISH returns to Asia, and we are delighted to host it in Shanghai—a vibrant metropolis that seamlessly blends heritage with innovation, offering an inspiring and welcoming environment for our global community.

ISH 2027 is jointly organised by the International Society of Hypertension (ISH) and the Chinese Hypertension League (CHL), in collaboration with the Shanghai Institute of Hypertension (SIH), the Chronic Disease Institute for Green Health in Hainan, China (CDIGH) and the Beijing Hypertension Association (BHA). Together, we are committed to advancing hypertension research, education, and clinical practice across the region and beyond.

At the heart of this congress lies the theme, “Innovations for Improving Blood Pressure Control.” Innovation is not merely a theme—it is the engine that drives better detection, smarter treatment, and more equitable care. In an era of rapid technological and biomedical advances, translating novel ideas into real‑world solutions is essential if we are to close the global gap in hypertension awareness, treatment, and control.

We are proud to host a series of inter‑society joint symposia, offering unparalleled opportunities for networking and knowledge exchange with eminent experts, thought leaders, and early‑career investigators from across the globe. The programme also includes plenary lectures, meet‑the‑expert sessions, interactive workshops, industry symposia, and dedicated oral and poster presentation tracks. Special awards and travel grants will be presented to outstanding early‑career researchers, women professionals, and authors of high‑impact scientific work.

Beyond presenting the latest scientific advances, our mission is to foster a platform where ideas can be transformed into collaborative solutions for the next five years. We warmly invite the pharmaceutical industry and technology innovators to engage actively, share perspectives, and develop joint initiatives with leading scientists and clinicians to advance cardiovascular prevention, treatment, and outcomes.

We sincerely hope you will join us in Shanghai for ISH 2027. We are confident that the stimulating academic exchange, combined with the city’s unique dynamism, will make this an unforgettable experience for all participants.

We look forward to welcoming you to Shanghai from 28–31 October 2027.

Co-Chairs: